Tone mix
Week by week 47 weeks
Share of Pacira BioSciences, Inc. Common Stock's 129 headlines over the last 52 weeks by the model's call, and the same mix week by week.
Biggest swings in the last year
The weeks whose tone moved furthest from the 8-week average, with the story most outlets carried that week.
- Week of Jun 29, 2026 · tone +100HC Wainwright Reaffirms "Buy" Rating for Pacira BioSciences (NASDAQ:PCRX)+86
- Week of Nov 17, 2025 · tone 0Pacira BioSciences, Inc. (NASDAQ:PCRX) Given Consensus Rating of "Hold" by Brokerages-58
- Week of Dec 8, 2025 · tone 0Insider Selling: Pacira BioSciences (NASDAQ:PCRX) CFO Sells 9,104 Shares of Stock-45
- Week of Nov 24, 2025 · tone +100Pacira BioSciences, Inc. (PCRX) Stock Analysis: Exploring A 30% Potential Upside In The Healthcare Sector+42
- Week of Jul 7, 2025 · tone +50Pacira BioSciences Gene Therapy Shows Sustained Knee Osteoarthritis Improvement+40
- Week of Aug 18, 2025 · tone 0Nuveen LLC Acquires Shares of 518,482 Pacira BioSciences, Inc. $PCRX-39
Daily headline tone, last 90 sessions
Hover a session for its totals; click to pin.
Each point is the average score of the headlines about Pacira BioSciences, Inc. Common Stock in one trading session, with the 8-session average drawn through it. Sessions with no headline about the company have no point.
Tone by period
Show the table · 3 rows, 3 columns
Scroll sideways to compare all columns. Select a heading to sort.
| Last 7 sessions | 0 | No headlines |
| Last 30 sessions | 24 | +41 |
| Last 90 sessions | 38 | +36 |
No matching rows. Clear the filter to see all records.
Every headline in the period counts equally.
Headlines on Tuesday, October 13, 2026
2 headlines, average tone 0: 0 positive, 2 neutral and 0 negative. Showing all 2.
- www.themarketsdaily.com · 1 outletPacira BioSciences, Inc. (NASDAQ:PCRX) Stock Now Rated "Hold" by Sell-Side BrokeragesNeutral
- www.prnewswire.com · 1 outletAre OPCH, PCRX, RXO, BOLD Obtaining Fair Deals for their Shareholders?Neutral
Show the table · 2 rows, 4 columns
Scroll sideways to compare all columns. Select a heading to sort.
| Pacira BioSciences, Inc. (NASDAQ:PCRX) Stock Now Rated "Hold" by Sell-Side Brokerages | www.themarketsdaily.com | 1 | Neutral |
| Are OPCH, PCRX, RXO, BOLD Obtaining Fair Deals for their Shareholders? | www.prnewswire.com | 1 | Neutral |
No matching rows. Clear the filter to see all records.
Headlines on Monday, October 12, 2026
7 headlines, average tone +14: 3 positive, 2 neutral and 2 negative. Showing all 7.
- www.prnewswire.com · 2 outletsSHAREHOLDER ALERT: The M&A Class Action Firm Announces An Investigation of Pacira BioSciences, Inc. (NASDAQ: PCRX)Neutral
- www.tickerreport.com · 1 outletPacira BioSciences (NASDAQ:PCRX) Cut to "Hold" at Truist FinancialNegative
- www.tickerreport.com · 1 outletPacira BioSciences (NASDAQ:PCRX) Cut to Hold at Needham & Company LLCNegative
- www.themarketsdaily.com · 1 outletPacira BioSciences (NASDAQ:PCRX) Upgraded at JPMorgan Chase & Co.Positive
- www.tickerreport.com · 1 outletPacira BioSciences (NASDAQ:PCRX) Price Target Raised to $36.50Positive
- www.dailypolitical.com · 1 outletPacira BioSciences' (PCRX) "Hold" Rating Reaffirmed at Truist FinancialPositive
- www.themarketsdaily.com · 1 outletInsider Selling: Pacira BioSciences (NASDAQ:PCRX) SVP Sells $217,920.00 in StockNeutral
Show the table · 7 rows, 4 columns
Scroll sideways to compare all columns. Select a heading to sort.
| SHAREHOLDER ALERT: The M&A Class Action Firm Announces An Investigation of Pacira BioSciences, Inc. (NASDAQ: PCRX) | www.prnewswire.com | 2 | Neutral |
| Pacira BioSciences (NASDAQ:PCRX) Cut to "Hold" at Truist Financial | www.tickerreport.com | 1 | Negative |
| Pacira BioSciences (NASDAQ:PCRX) Cut to Hold at Needham & Company LLC | www.tickerreport.com | 1 | Negative |
| Pacira BioSciences (NASDAQ:PCRX) Upgraded at JPMorgan Chase & Co. | www.themarketsdaily.com | 1 | Positive |
| Pacira BioSciences (NASDAQ:PCRX) Price Target Raised to $36.50 | www.tickerreport.com | 1 | Positive |
| Pacira BioSciences' (PCRX) "Hold" Rating Reaffirmed at Truist Financial | www.dailypolitical.com | 1 | Positive |
| Insider Selling: Pacira BioSciences (NASDAQ:PCRX) SVP Sells $217,920.00 in Stock | www.themarketsdaily.com | 1 | Neutral |
No matching rows. Clear the filter to see all records.
Headlines on Friday, October 9, 2026
10 headlines, average tone +68: 7 positive, 3 neutral and 0 negative. The 8 most widely carried stories are listed; the table holds all 10.
- www.fool.com · 3 outletsWhy Pacira BioSciences Skyrocketed TodayPositive
- www.investors.com · 2 outletsPacira Biosciences Snags $1.65 Billion Takeover Deal; Shares FlyPositive
- www.rttnews.com · 2 outletsBiotech Stocks At 52-Week Highs - PCRX +44% On Acquisition News; MANE+14%, HAE+17%, CON, HSTMPositive
- www.rttnews.com · 2 outletsViatris Agrees To Acquire Pacira BioSciences In $1.65 Bln Cash DealPositive
- www.investorideas.com · 1 outletPacira BioSciences (Nasdaq: PCRX) Makes 52 Week High on Acquisition NewsPositive
- seekingalpha.com · 1 outletPacira BioSciences jumps 44% on Viatris acquisition deal (PCRX:NASDAQ)Positive
- www.law360.com · 1 outletViatris To Buy Pacira BioSciences For $1.65BPositive
- www.themarketsdaily.com · 1 outletPacira BioSciences' (PCRX) Hold Rating Reiterated at Jefferies Financial GroupNeutral
Show the table · 10 rows, 4 columns
Scroll sideways to compare all columns. Select a heading to sort.
| Why Pacira BioSciences Skyrocketed Today | www.fool.com | 3 | Positive |
| Pacira Biosciences Snags $1.65 Billion Takeover Deal; Shares Fly | www.investors.com | 2 | Positive |
| Biotech Stocks At 52-Week Highs - PCRX +44% On Acquisition News; MANE+14%, HAE+17%, CON, HSTM | www.rttnews.com | 2 | Positive |
| Viatris Agrees To Acquire Pacira BioSciences In $1.65 Bln Cash Deal | www.rttnews.com | 2 | Positive |
| Pacira BioSciences (Nasdaq: PCRX) Makes 52 Week High on Acquisition News | www.investorideas.com | 1 | Positive |
| Pacira BioSciences jumps 44% on Viatris acquisition deal (PCRX:NASDAQ) | seekingalpha.com | 1 | Positive |
| Viatris To Buy Pacira BioSciences For $1.65B | www.law360.com | 1 | Positive |
| Pacira BioSciences' (PCRX) Hold Rating Reiterated at Jefferies Financial Group | www.themarketsdaily.com | 1 | Neutral |
| Pacira BioSciences to Be Acquired by Viatris for $1.65B | www.miragenews.com | 1 | Neutral |
| PCRX SHAREHOLDER ALERT: ADEMI LLP INVESTIGATES WHETHER BUYOUT FAIRLY VALUES PACIRA BIOSCIENCES, INC. | www.prnewswire.com | 1 | Neutral |
No matching rows. Clear the filter to see all records.
Headlines on Thursday, October 8, 2026
3 headlines, average tone +65: 2 positive, 1 neutral and 0 negative. Showing all 3.
- www.tickerreport.com · 1 outletPacira BioSciences (NASDAQ:PCRX) Shares Climb 4.7% Following Analyst UpgradePositive
- seekingalpha.com · 1 outletViatris to buy Pacira BioSciences in $1.65B deal (VTRS:NASDAQ)Positive
- www.rttnews.com · 1 outletPacira BioSciences Reports Caregiver Survey Findings On Postsurgical RecoveryNeutral
Show the table · 3 rows, 4 columns
Scroll sideways to compare all columns. Select a heading to sort.
| Pacira BioSciences (NASDAQ:PCRX) Shares Climb 4.7% Following Analyst Upgrade | www.tickerreport.com | 1 | Positive |
| Viatris to buy Pacira BioSciences in $1.65B deal (VTRS:NASDAQ) | seekingalpha.com | 1 | Positive |
| Pacira BioSciences Reports Caregiver Survey Findings On Postsurgical Recovery | www.rttnews.com | 1 | Neutral |
No matching rows. Clear the filter to see all records.
Headlines on Wednesday, October 7, 2026
1 headline, average tone 0: 0 positive, 1 neutral and 0 negative. Showing all 1.
- www.manilatimes.net · 1 outletPacira BioSciences and Caregiver Action Network Announce New Survey on Gaps in Preparing Families for Postsurgical Recovery at HomeNeutral
Show the table · 1 row, 4 columns
Scroll sideways to compare all columns. Select a heading to sort.
| Pacira BioSciences and Caregiver Action Network Announce New Survey on Gaps in Preparing Families for Postsurgical Recovery at Home | www.manilatimes.net | 1 | Neutral |
No matching rows. Clear the filter to see all records.
How the score works
A headline's tone is not a forecast of the share price. Read the headlines themselves before acting on an average.
Which headlines count
Headlines come from the GDELT global news feed from 2019-09-23 on. A headline counts only when a model judges it to be about Pacira BioSciences, Inc. Common Stock, not a passing mention.
How each headline is scored
The model calls each headline positive, neutral or negative news for the company. A period's tone is the share of positive minus negative headlines, from -100 (all negative) to +100 (all positive).
When a headline counts
Headlines published by 9:15 a.m. New York time belong to that day's session. Later and weekend headlines move to the next trading session.
Repeated stories
When several outlets carry the same headline, it counts once per session.